Fingerprint
Dive into the research topics of 'SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: Patient selection and perspectives'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: Patient selection and perspectives
Holly E. Gurgle, Karen White, Carrie McAdam-Marx
Research output: Contribution to journal › Review article › peer-review
36
Scopus
citations